These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38525200)

  • 1. American Gastroenterological Association-Proposed Fecal Calprotectin Cutoff of 50 ug/g is Associated With Endoscopic Recurrence in a Real-World Cohort of Patients With Crohn's Disease Post-ileocolic Resection.
    Li T; Shah R; Click B; Cohen BL; Barnes E; Joseph A; Bachour S; Hu J; Contreras S; Li E; Axelrad J
    Crohns Colitis 360; 2024 Jan; 6(1):otae016. PubMed ID: 38525200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Calprotectin and Modified Rutgeerts Score.
    Lopes S; Andrade P; Afonso J; Rodrigues-Pinto E; Dias CC; Macedo G; Magro F
    Inflamm Bowel Dis; 2016 Sep; 22(9):2173-81. PubMed ID: 27482974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.
    Baillet P; Cadiot G; Goutte M; Goutorbe F; Brixi H; Hoeffel C; Allimant C; Reymond M; Obritin-Guilhen H; Magnin B; Bommelaer G; Pereira B; Hordonneau C; Buisson A
    World J Gastroenterol; 2018 Feb; 24(5):641-650. PubMed ID: 29434453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Levels of Fecal Calprotectin 3 Months After Surgery Predict Subsequent Endoscopic Postoperative Remission in Crohn's Disease.
    Veyre F; Boschetti G; Meunier C; Cuerq C; Gay C; Charlois AL; Duclaux-Loras R; Danion P; Cotte E; Kepenekian V; Mialon A; Faure M; Roblin X; Flourie B; Nancey S
    Dig Dis Sci; 2021 Dec; 66(12):4429-4435. PubMed ID: 33387123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic Evaluation at 1 Month After Ileocolic Resection for Crohn's Disease Predicts Future Postoperative Recurrence and Is Safe.
    Guo Z; Zhu Y; Xu Y; Cao L; Li Y; Gong J; Wang Z; Zhu W
    Dis Colon Rectum; 2022 Mar; 65(3):382-389. PubMed ID: 34759245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Keenan JI; Leach S; Burgess L; Aitchison A; Gorelik A; Liew D; Day AS; Gearry RB
    Inflamm Bowel Dis; 2016 May; 22(5):1086-94. PubMed ID: 26818420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn's Disease.
    Li T; Click B; Bachour S; Sachs M; Barnes EL; Cohen BL; Contreras S; Axelrad J
    Dig Dis Sci; 2023 Sep; 68(9):3596-3604. PubMed ID: 37548896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn's disease patients with anastomotic strictures.
    Lopes S; Andrade P; Rodrigues-Pinto E; Afonso J; Macedo G; Magro F
    World J Gastroenterol; 2017 Sep; 23(35):6482-6490. PubMed ID: 29085198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease.
    Verdejo C; Hervías D; Roncero Ó; Arias Á; Bouhmidi A; Lorente R; Salueña I; Lucendo AJ
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1521-1527. PubMed ID: 30303822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Calprotectin for Small Bowel Crohn's Disease: Is It a Cutoff Issue?
    Romero-Mascarell C; Fernández-Esparrach G; Rodríguez-De Miguel C; Masamunt MC; Rodríguez S; Rimola J; Urpí M; Casanova GS; Ordás I; Ricart E; Caballol B; Fernández-Clotet A; Panés J; Llach J; González-Suárez B
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of fecal calprotection in predicting endoscopic recurrence in postoperative Crohn's disease.
    Primas C; Hopf G; Reinisch S; Baumann L; Novacek G; Reinisch W; Vogelsang H
    Scand J Gastroenterol; 2021 Oct; 56(10):1169-1174. PubMed ID: 34314308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy.
    Lasson A; Strid H; Ohman L; Isaksson S; Olsson M; Rydström B; Ung KA; Stotzer PO
    J Crohns Colitis; 2014 Aug; 8(8):789-95. PubMed ID: 24418661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of tissue calprotectin for disease recurrence after ileocecal resection in pediatric Crohn's disease.
    Zarubova K; Fabian O; Hradsky O; Lerchova T; Mikus F; Dotlacil V; Pos L; Skaba R; Bronsky J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):297-303. PubMed ID: 34446936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Markers of Crohn's Disease in Small Bowel Capsule Endoscopy: A Retrospective Study of Small Bowel Capsule Endoscopy.
    Mattila J; Stenholm T; Löyttyniemi E; Koffert J
    J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysis.
    Rivière P; Pekow J; Hammoudi N; Wils P; De Cruz P; Wang CP; Mañosa M; Ollech J; Allez M; Nachury M; Kamm MA; Ahanori M; Ferrante M; Buisson A; Singh S; Laharie D; Diouf M; Fumery M
    J Crohns Colitis; 2023 Mar; 17(2):269-276. PubMed ID: 36124813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.